Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
2018
Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination treatment with surgery, radiotherapy, and chemotherapy, the prognosis for glioma patients is still extremely poor. Compared with the poor outcome and slowly developing technologies for surgery and radiotherapy, the application of targeted chemotherapy with a new mechanism has become a research focus in this field.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
95
References
32
Citations
NaN
KQI